Home LiteratureArticle Details
PMID: 10506238 Published · ppublish English Journal Article Review

Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society.

Pediatrics ·Vol. 104 ·No. 4 Pt 1 ·1999-10-00 ·Pages 936-41

Kaplowitz PB, Oberfield SE

Abstract

In 1997 a study from the Pediatric Research in Office Settings network, based on pubertal staging of >17,000 girls between 3 and 12 years of age, indicated that breast and pubic hair development are occurring significantly earlier than suggested by our current guidelines, especially in African-American girls. In response to this article, the Lawson Wilkins Pediatric Endocrine Society undertook a comprehensive review of this topic. The primary conclusions of this review are: 1. The current recommendation that breast development before age 8 is precocious is based on outdated studies. Until 1997, no data were available on pubertal staging in US girls that could have documented a trend to earlier maturation. 2. The 1997 study indicates that stage 2 of breast and pubic hair development is being achieved ~1 year earlier in white girls and 2 years earlier in African-American girls than previous studies have shown. 3. Concerns that girls with moderately precocious puberty will be significantly short adults are overstated; most have adult height within the normal range. 4. Therapy with gonadotropin-releasing hormone agonists has not been proven to have a substantial effect on adult height in most girls whose puberty starts between 6 and 8 years of age. 5. New guidelines propose that girls with either breast development or pubic hair should be evaluated if this occurs before age 7 in white girls and before age 6 in African-American girls. No changes in the current guidelines for evaluating boys (signs of puberty at younger than 9 years) can be made at this time.normal puberty, breast development, pubic hair.

MeSH Terms
Age of Onset Breast/growth & development Child Child, Preschool Female Fertility Agents, Female/therapeutic use Gonadotropin-Releasing Hormone/therapeutic use Growth Disorders/etiology,prevention & control Humans Practice Guidelines as Topic Puberty/physiology Puberty, Precocious/complications,diagnosis,drug therapy,epidemiology Reference Values United States/epidemiology
Chemicals
Fertility Agents, Female Gonadotropin-Releasing Hormone
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kaplowitz P B
Department of Pediatrics, the Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia, USA. pkaplowitz@hsc.vcu.edu
Oberfield S E
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
0031-4005
Published
1999-10-00
Pages
936-41
Language
English
Region
United States
NLM ID
0376422
Subset
IM
Corrections
CommentIn
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com